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This daily COVID-19 Health Evidence Summary is to signpost DFID and other UK government 
departments to the latest relevant evidence and discourse on COVID-19 to inform and support 
their response. It is a result of 3 hours of work and is not intended to be a comprehensive summary 
of available evidence on COVID-19 but aims to make original documents easily accessible to 
decision makers which, if relevant to them, they should go to before making decisions.   
Infection Prevention and Control 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
04.06.20 The natural 
history and 
transmission 
potential of 
asymptomatic 
SARS-CoV-2 
infection 
Clinical 
infectious 
diseases 
 A massive coronavirus 
testing campaign in 
Vietnam has found 
evidence that infected 
people who never show any 
symptoms can pass the 
virus to others. 
 Early in the global COVID-
19 outbreak, Vietnam 
began to repeatedly test 
people at high risk of 
infection. Those who tested 
positive were admitted to a 
hospital until they either 
recovered or tested 
negative. 
 Of roughly 14,000 people 
tested between mid-March 
and early April, 49 were 
infected. Le Van Tan at the 
Oxford University Clinical 
Research Unit in Ho Chi 
Minh City, Vietnam, and his 
colleagues monitored 30 of 
the 49 individuals and found 
that 13 developed no 
testing 
2 
symptoms during their 
hospital stay 
  
Vaccines 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
10.06.20 Generation of 
a Broadly 
Useful Model 
for COVID-19 
Pathogenesis 
Vaccination, 
and 
Treatment 
Cell | Article 
 It is critical that 
vaccines and 
therapeutics be 
developed very 
rapidly. Mice, the 
ideal animal for 
assessing such 
interventions, are 
resistant to SARS-
CoV-2. 
 Article describes a 
murine model of 
broad and 
immediate utility to 
investigate COVID-
19 pathogenesis, 
and to evaluate new 
therapies and 
vaccines. 
  
mouse 
model, 
pathogenesis, 
therapeutics, 
vaccine 
10.06.20 Neuropilin-1 
facilitates 
SARS-CoV-2 
cell entry and 
provides a 
possible 
pathway into 
the central 
nervous 
system 
bioRxiv | 
Preprint (not 
peer 
reviewed) 
  
 Researchers have 
found a second 
protein that SARS-
CoV-2 uses to enter 
human cells, 
potentially offering a 
new target for 
vaccines and drugs. 
 The SARS-CoV-2 
protein called Spike 
is known to attach 
to a human protein 
called ACE2, which 
allows the virus to 
enter cells. Two 
teams of 
vaccine 
3 
researchers have 
now found that the 
human protein 
neuropilin-1 (NRP1) 
also aids viral 
invasion. 
 Peter Cullen and 
Yohei Yamauchi at 
the University of 
Bristol, UK, and 
their colleagues 
showed that a 
fragment of the 
Spike protein can 
bind to NRP1 
05.06.20 Neuropilin-1 is 
a host factor 
for SARS-
CoV-2 
infection 
bioRxiv | 
Preprint (not 
peer 
reviewed) 
 This team found 
that in mice, NRP1 
assists the entry of 
virus-sized particles 
into the central 
nervous system.  
 The two studies 
suggest that 
blocking the 
interaction between 
the virus and NRP1 
could provide a way 
to combat 
coronavirus 
infection. 
Vaccine 
Comments, Editorials, Opinions, Blogs, News 
Publication 
date 
Title/URL Journal | Article 
type 
Author(s) 
11.06.2020 Socio-demographic and 
epidemiological consideration of 
Africa’s COVID-19 response: what is 
the possible pandemic course? 
Nature Medicine | 
Comment 
Bamba Gaye et 
al. 
09.06.20 Update Alert: Epidemiology of and Risk 
Factors for Coronavirus Infection in 
Health Care Workers 
Annals of Internal 
Medicine | Letter 
Roger Chou, 
Tracy 
Dana,  David I. 
4 
Buckley, Shelley 
Selph, 
09.06.20 When the Dust Settles: Preventing a 
Mental Health Crisis in COVID-19 
Clinicians 
Annals of Internal 
Medicine | Ideas 
and opinions 
Stephanie B. 
Kiser, Rachelle 
E. Bernacki, 
09.06.20 The Impact of COVID-19 on Food 
Security and Nutrition             
UN | Policy Brief   
10.06.20 The Importance of Proper Death 
Certification During the COVID-19 
Pandemic 
JAMA | Viewpoint James R. Gill, 
Maura E. 
DeJoseph, DO 
10.06.20 Hydroxychloroquine side-effects raise 
concerns for rheumatology patients  
Lancet 
Rheumatology | 
News 
Brian Owens 
Dashboards & Trackers 
Cases & 
deaths: 
Global 
Cases & 
deaths: 
Regional 
Cases & 
deaths: 
Country 
Living 
evidence & 
policy maps 
Current 
research 
including trials 
  Diagnostics  Treatments   Vaccines 
WHO sitreps WHO 
Africa 
Ghana COVID-
NMA 
WHO   FIND 
SARS-CoV-
2 Test 
Tracker 
  Global 
COVID-19 
Clinical Trial 
Tracker 
  CEPI 
WHO 
dashboard 
African 
Arguments 
Indonesia EPPI 
Centre 
WHO 
International 
Clinical Trials 
Registry 
Platform 
(ICTRP) 
 FIND 
SARS-CoV-
2 
Diagnostics: 
performance 
data 
  US NIH 
registered 
clinical trials 
Vaccine 
Centre 
LSHTM 
Johns 
Hopkins 
University 
European 
CDC 
Nigeria 
CDC 
Norwegian 
Institute of 
Public 
Health 
Cytel  Serology-
based tests 
for COVID-
19 
  Solidarity 
trial 
 COVID-
19 Oxford 
Vaccine 
Trial 
5 
WEF 
  Sierra 
Leone 
 Oxford C19 
Government 
Response 
Tracker 
(OxCGRT) 
US NIH  Our World 
in Data: C19 
Testing 
  COVID-19 
Therapeutics 
Accelerator 
  
Our World in 
Data 
  Singapore  Our World 
in Data: 
C19 Policy 
responses 
COVID-
evidence 
      
Global 5050 
  UK  IFPRI 
COVID-19 
Policy 
Response 
Portal 
Cochrane       
CEBM, 
University of 
Oxford 
  US  COVID-19 
Primer 
Clinicaltrials.gov       
Humanitarian 
Data 
Exchange 
     NIH 
LitCovid 
 UKCDR       
Information 
is Beautiful 
     WHO 
COVID-19 
Database 
        
LSHTM               
HealthMap 
(cases) 
              
The 
Commons 
Project 
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C19 Resource Hubs 
Global  Regional & 
Country 
Academic 
journals & 
Publishers 
Institutes/Centres
/Funders/Other 
Health Topics   Social 
Sciences 
WHO COVID-
19 pandemic  
Africa CDC Annals of 
Internal 
Medicine 
LSTM Stop TB 
Partnership 
  SSHAP 
WHO risk 
communication 
African 
Union 
BMJ LSHTM 
 
  IDA 
WHO Q&A Nigeria 
CDC 
Bulletin of 
the WHO 
ICL MRC Centre 
for Global 
Infectious 
Disease Analysis 
Global 
Menstrual 
Collective  
  Disability and 
inclusion 
WHO Global 
research 
GeoPoll: 
SSA 
Cambridge 
University 
Press 
ODI SLH: 
Handwashing 
in low 
resource 
settings 
  Coregroup 
IDDC 
COVID-19 
Solidarity 
Response Fund 
Global 
Health 
Network 
Africa 
Cell Press Johns Hopkins 
University 
RBM 
Partnership 
  Ethics, health 
systems & 
COVID-19 
UN African 
Academy of 
Sciences 
Cochrane  Center for Global 
Development 
    Social 
Development 
Direct C19 
blog series 
UN Women Africa 
Evidence 
Network 
Elsevier CMMID 
Repository 
    
UNOCHA OCHA 
Southern 
and Eastern 
Africa 
JAMA 
Network 
Norwegian 
Institute of Public 
Health 
    
7 
COVID-19 
Digest 
UNHCR  South 
African 
Government 
The 
Lancet 
Oxford Centre for 
Evidence-based 
Medicine 
    
UNICEF   medRxiv 
and 
bioRxiv 
(Preprints) 
 HEART     
UNESCO   NEJM  UKRI     
UN WFP   Oxford 
University 
Press 
 Evidence Aid     
GOARN   PLoS  NIH     
EPI-WIN   SAGE 
journals 
IFPRI Resources 
and Analyses of 
C19 Impact 
    
World Bank   Science  Prevent 
Epidemics  
    
Our World in 
Data 
  Springer 
Nature 
      
COVID-19 
Narratives by 
David Nabarro 
  SSRN 
(Preprints)  
      
Reliefweb   Wiley       
Humanitarian 
OpenStreetMap 
Team 
          
Global 
Partnership for 
  
 
      
8 
Sustainable 
Development 
Data 
WorldPop           
Flowminder           
COVID-END           
Premise 
COVID-19 
Global Impact 
Study 
    
  
Online learning & events 
Date Title/URL Online 
learning/event 
Duration Lead 
Available 
now 
Standard precautions: 
Environmental 
cleaning and 
disinfection 
Online course 1 hour WHO 
16.06.2020 Africa beyond COVID-
19 
Virtual event 1h 30 
hours 
ODI 
15.06.2020 Poverty monitoring in 
the context of Covid-
19 
Virtual event 1h 15 ODI 
Available 
now 
COVID-19: Effective 
Nursing in Times of 
Crisis 
Online course 2 weeks – 
2 hours per 
week 
Johns Hopkins School 
of Nursing 
          
Available 
now 
WHO Academy and 
WHO Info mobile 
applications 
Mobile app   WHO 
9 
Available 
now 
COVID-19: 
Pandemics, Modelling 
and Policy 
Online 
learning 
2 weeks | 2 
hours 
weekly 
study 
FutureLearn UNESCO 
UNITWIN Complex 
Systems Digital 
Campus/Open 
University 
12.05.2020 COVID-19 and 
maintaining quality 
essential health 
services  
Webinar 1 hour WHO & ISQua – Dr 
Shams Syed, Dr Peter 
Lachman, Dr Teri 
Rynolds & Dr Ed Kelley 
11.5.2020 COVID-19 Contact 
Tracing course 
Online 
learning 
5 hours Johns Hopkins 
Bloomberg School of 
Health 
7-28 May 
2020 
Virtual Evidence 
Weeks 
5 sessions 1h 30 International Initiative 
for Impact Evaluation 
(3ie) 
Tuesdays at 
1700 CEST 
(Geneva 
time) & 
Thursdays 
0830 CEST 
(Geneva 
time) 
COVID-19 Open 
online brief with Dr 
David Nabarro 
Event 1h 4SD 
30.04.2020 Professor Chris 
Whitty’s Gresham 
lecture on COVID-19 
Event 1h 20 Gresham College 
Available 
now 
Emerging respiratory 
viruses, including 
COVID-19: methods 
for detection, 
prevention, response 
and control 
Online 
learning 
3 hours WHO 
Available 
now 
Responding to 
COVID-19: Real-time 
training for the 
Online 
learning 
Multiple 
self-paced 
course 
WHO 
10 
coronavirus disease 
outbreak 
25 May 
2020 
COVID-19: Tackling 
the Novel Coronavirus 
Online 
learning 
3 weeks | 4 
hours 
weekly 
study 
FutureLearn 
LSHTM/UK PHRST 
Available 
online now 
without 
mentors. 
Updated 
version will 
commence 
early June 
2020 
COVID-19 
Diagnostics and 
Testing 
Online 
learning 
3 weeks | 3 
hours 
weekly 
study 
FutureLearn 
FIND/LSHTM/ASLM 
6 April 2020 COVID-19 Critical 
Care: Understanding 
and Application 
Online 
learning 
5 weeks | 1 
hour 
weekly 
study 
FutureLearn University 
of Edinburgh & Royal 
College of Physicians 
of Edinburgh  
Available 
now 
COVID-19 supporting 
online courses 
Online 
learning 
Multiple 
self-paced 
course 
BMJ Learning 
  
11 
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Rapid review methodology 
The rapid daily search for peer-reviewed literature is carried out through a PubMed search with the following 
keywords (“COVID-19” OR “severe acute respiratory syndrome coronavirus 2” OR “2019-nCoV” OR “SARS-CoV-
2” OR “2019nCoV” OR “coronavirus” ) AND (“Africa”) OR (“equity” OR “equities”) OR (“poverty”), restricted to 
articles published in the previous 2 to 3 days, in English. This is complemented by a search of the homepage of 
the following high-impact global health journals: The Lancet journals, New England Journal of Medicine, Nature, 
JAMA, Annals of Internal Medicine, Cochrane Reviews, BMJ Global Health, the PLoS journals and a Twitter 
search of their Twitter pages. A search also of preprints from bioRxiv and medRxiv. Please note that papers that 
have not been peer-reviewed are highlighted in red. All primary research papers that relate to the primary and 
secondary impacts of the COVID-19 response in LMICs, and disease control and health system responses are 
included. Articles related to tackling the secondary impacts on other sectors are not included. Additional 
commentaries, opinions, and commissioned pieces are selected based on relevance. 
The search for dashboards, guidelines, tools, editorials, comments, blogs, opinions and news is through the 
academic journals listed above, C19 resource hubs and following lead academics and professionals on Twitter. 
About this report 
This daily COVID-19 health evidence summary (HES) is based on 3 hours of desk-based research. The 
summary is not intended to be a comprehensive summary of available evidence on COVID-19 but aims to make 
original documents easily accessible to decision makers which, if relevant to them, they should go to before 
making decisions. The HES are not intended to replace medical or professional advice and the researcher or the 
K4D consortium cannot be held responsible for any decisions made about COVID-19 on the basis of the HES 
alone. K4D services are provided by a consortium of leading organisations working in international development, 
led by the Institute of Development Studies (IDS), with Education Development Trust, Itad, University of Leeds 
Nuffield Centre for International Health and Development, Liverpool School of Tropical Medicine (LSTM), 
University of Birmingham International Development Department (IDD) and the University of Manchester 
Humanitarian and Conflict Response Institute (HCRI). 
This evidence summary was prepared for the UK Government’s Department for 
International Development (DFID) and its partners in support of pro-poor programmes. 
It is licensed for non-commercial purposes only. K4D cannot be held responsible for 
errors, omissions or any consequences arising from the use of information contained in 
this health evidence summary. Any views and opinions expressed do not necessarily 
reflect those of DFID, K4D or any other contributing organisation.  
© DFID - Crown copyright 2020. 
 
